August 31, 2015 writer

TSO3 to present at the 4th Annual Liolios Gateway Conference on September 10, 2015

Québec City,  August 28, 2015 — TSO3 Inc. (TSX: TOS) (“TSO3” or the “Company”) an innovator in sterilization technology for medical devices in healthcare settings, has been invited to present at the 2015 Liolios Gateway Conference being held on September 9-10, 2015 at the Four Seasons Hotel San Francisco.

TSO3 management is scheduled to present on Thursday, September 10 at 12:30 p.m. Pacific time, with one-on-one meetings held throughout the conference. Management will discuss the Company’s performance and its outlook for 2015.

The presentation will be webcast live and available for replay at http://wsw.com/webcast/liolios/tos and via the investor relations section of the company’s website at www.tso3.com.

To receive additional information, request an invitation or to schedule a one-on-one meeting, please email gateway@liolios.com or call Chris Tyson at (949) 574-3860.

About the Gateway Conference

The 4th Annual Gateway Conference is an invite-only conference presented by Liolios, which brings together the most compelling companies with the nation’s top institutional investors and analysts. This year’s event features more than 90 companies from a number of growth industries, including technology, business and financial services, consumer, digital media, clean technology and life sciences. The format has been designed to give attendees direct access to senior management via company presentations, Q&A sessions and one-on-one meetings. For more information, visit www.gateway-conference.com or www.liolios.com.

About TSO3

Founded in 1998, TSO3’s activities encompass the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment that offer an advantageous replacement solution to other low temperature sterilization processes currently used in hospitals. It also offers services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes. For more information about TSO3, visit the Company’s Web site at www.tso3.com.

Safe Harbor Statement

The statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO3) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favorable terms and other risks and uncertainties.

The TSX has neither approved nor disapproved the information contained herein and accepts no responsibility for it.

Back to Posts